Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outreach and support in South-London (OASIS) 2001—2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis
Paolo Fusar‐Poli, Thomas Spencer, Andrea De Micheli, et al.
European Neuropsychopharmacology (2020) Vol. 39, pp. 111-122
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
Marco Solmi, Joaquim Raduà, Miriam Olivola, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 281-295
Open Access | Times Cited: 2179
Preventive psychiatry: a blueprint for improving the mental health of young people
Paolo Fusar‐Poli, Christoph U. Correll, Celso Arango, et al.
World Psychiatry (2021) Vol. 20, Iss. 2, pp. 200-221
Open Access | Times Cited: 326
Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction
Elena Dragioti, Joaquim Raduà, Marco Solmi, et al.
World Psychiatry (2023) Vol. 22, Iss. 1, pp. 86-104
Open Access | Times Cited: 73
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice
Paolo Fusar‐Poli, Mirko Manchia, Nikolaos Koutsouleris, et al.
European Neuropsychopharmacology (2022) Vol. 63, pp. 17-34
Open Access | Times Cited: 64
Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis
Gonzalo Salazar de Pablo, Ana Catalán, Julio Vaquerizo Serrano, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 1, pp. 282-294
Open Access | Times Cited: 25
Salivary cortisol measures across the clinical stages of psychosis: An individual participant data (IPD) meta-analysis
Susanne Häußler, Uzma Zahid, Fern Day, et al.
Psychoneuroendocrinology (2025), pp. 107283-107283
Closed Access | Times Cited: 1
Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis
Dominic Oliver, Maite Arribas, Joaquim Raduà, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3670-3678
Open Access | Times Cited: 29
The ‘Parma At‐Risk mental states’ (PARMS) program: General description and process analysis after 5 years of clinical activity
Lorenzo Pelizza, Emanuela Leuci, Emanuela Quattrone, et al.
Early Intervention in Psychiatry (2023) Vol. 17, Iss. 6, pp. 625-635
Closed Access | Times Cited: 18
Transition to Schizophrenia Spectrum Disorder Following Emergency Department Visits Due to Substance Use With and Without Psychosis
Daniel T. Myran, Lyndsay D. Harrison, Michael Pugliese, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 11, pp. 1169-1169
Closed Access | Times Cited: 17
The lived experience of mental disorders in adolescents: a bottom‐up review co‐designed, co‐conducted and co‐written by experts by experience and academics
Paolo Fusar‐Poli, Andrés Estradé, Cecilia Maria Esposito, et al.
World Psychiatry (2024) Vol. 23, Iss. 2, pp. 191-208
Open Access | Times Cited: 8
Autism Spectrum Disorder and Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis
Julio Vaquerizo‐Serrano, Gonzalo Salazar de Pablo, Jatinder Singh, et al.
Journal of Autism and Developmental Disorders (2021) Vol. 52, Iss. 4, pp. 1568-1586
Open Access | Times Cited: 31
Public health primary prevention implemented by clinical high-risk services for psychosis
Andrés Estradé, Gonzalo Salazar de Pablo, Alice Zanotti, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Physical Health and Transition to Psychosis in People at Clinical High Risk
Andrea De Micheli, Umberto Provenzani, Kamil Krakowski, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 523-523
Open Access | Times Cited: 4
Predictors of Readmission in Young Adults with First-Episode Psychosis: A Multicentric Retrospective Study with a 12-Month Follow-Up
Filippo Besana, Serena Chiara Civardi, F. Mazzoni, et al.
Clinics and Practice (2024) Vol. 14, Iss. 4, pp. 1234-1244
Open Access | Times Cited: 4
Digital sleep phenotype and wrist actigraphy in individuals at clinical high risk for psychosis and people with schizophrenia spectrum disorders: a systematic review and meta-analysis
Rosario Aronica, Edoardo G. Ostinelli, Charlotte Austin, et al.
BMJ Mental Health (2025) Vol. 28, Iss. 1, pp. e301337-e301337
Open Access
Preventing psychosis in people at clinical high risk: an updated meta-analysis by the World Psychiatric Association Preventive Psychiatry section
Amedeo Minichino, Cathy Davies, Olga Karpenko, et al.
Molecular Psychiatry (2025)
Open Access
The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence
Alexis E. Cullen, Javier Labad, Dominic Oliver, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 3, pp. 350-377
Open Access | Times Cited: 10
Prevalence of tobacco smoking in people at clinical high-risk for psychosis: Systematic review and meta-analysis
Andrea De Micheli, Umberto Provenzani, Marco Solmi, et al.
Schizophrenia Research (2023) Vol. 254, pp. 109-115
Open Access | Times Cited: 8
Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High Risk for Psychosis
Nicholas R Livingston, Andrea De Micheli, Robert A. McCutcheon, et al.
Schizophrenia Bulletin (2024)
Open Access | Times Cited: 2
Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis
Nicholas R Livingston, Amanda Kiemes, Gabriel A. Devenyi, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 9, pp. 1448-1458
Open Access | Times Cited: 2
Transition to psychosis in randomized clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis
Gonzalo Salazar de Pablo, Cathy Davies, Héctor de Diego, et al.
European Psychiatry (2021) Vol. 64, Iss. 1
Open Access | Times Cited: 15
Physical Health in Clinical High Risk for Psychosis Individuals: A Cross-Sectional Study
Umberto Provenzani, Andrea De Micheli, Stefano Damiani, et al.
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 128-128
Open Access | Times Cited: 5
Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study
Dominic Oliver, Cathy Davies, Fernando Zelaya, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5
Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk
Cathy Davies, Matthijs G. Bossong, Daniel Martins, et al.
Schizophrenia Bulletin Open (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 4
Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol
Cathy Davies, Matthijs G. Bossong, Daniel Martins, et al.
Psychological Medicine (2023) Vol. 54, Iss. 5, pp. 993-1003
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top